The applications of eutectic systems, including deep eutectic solvents (DESs), in diverse
sectors have drawn significant interest from researchers, academicians, engineers, medical …

Despite efforts made to develop efficient preventive strategies, infections with influenza A
viruses (IAV) continue to cause serious clinical and economic problems. Current licensed …

Here, we describe the discovery of a naturally occurring human antibody (Ab), FluA-20, that
recognizes a new site of vulnerability on the hemagglutinin (HA) head domain and reacts …

Humans are repeatedly exposed to variants of influenza virus throughout their lifetime. As a
result, preexisting influenza-specific memory B cells can dominate the response after …

Influenza viruses remain a severe threat to human health, causing up to 650,000 deaths
annually,. Seasonal influenza virus vaccines can prevent infection, but are rendered …

The aim of candidate universal influenza vaccines is to provide broad protection against
influenza A and B viruses. Studies have demonstrated that broadly reactive antibodies …

The generation of strain-specific neutralizing antibodies against influenza A virus is known
to confer potent protection against homologous infections. The majority of these antibodies …

Autoantibodies against leucine-rich glioma inactivated 1 (LGI1) are found in patients with
limbic encephalitis and focal seizures. Here, we generate patient-derived monoclonal …

IgA is the second most abundant antibody present in circulation and is enriched at mucosal
surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens …

Influenza virus strain-specific monoclonal antibodies (mAbs) provide protection independent
of Fc gamma receptor (FcγR) engagement. In contrast, optimal in vivo protection achieved …